Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Arena Pharmaceuticals Announces Profitable Fourth Quarter With Sequential Quarterly Revenue Growth of 76% and Quarterly EPS of $0.05
Arena Pharmaceuticals Announces Profitable Fourth Quarter With Sequential Quarterly Revenue Growth of 76% and Quarterly EPS of $0.05 SAN DIEGO, Jan. 18 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today reported results for the quarter ended December 31, 2000.
View HTML
Toggle Summary Arena Pharmaceuticals, Inc. Expects First Profitable Quarter, Strong Fourth Quarter 2000 Results and Sets Conference Call
<ul><li> First Profitable Quarter</li> <li> Gross Revenue From Collaborations Reaches $4 Million, Up approximately 70% Over Third Quarter Net Income for the Quarter Exceeds $1 Million</li></ul>
View HTML
Toggle Summary Arena Pharmaceuticals Announces 2000 Third Quarter Results; Sequential Quarterly Revenue Growth of 79%
Arena Pharmaceuticals Announces 2000 Third Quarter Results; Sequential Quarterly Revenue Growth of 79% SAN DIEGO, Oct. 25 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA - news ) today reported results for the quarter ended September 30, 2000.
View HTML
Toggle Summary Arena Pharmaceuticals, Inc. to Provide Telephone and Internet Access For Third Quarter Earnings Conference Call Wednesday, October 25, Live at 4:30 p.m. Eastern Time
Arena Pharmaceuticals, Inc. to Provide Telephone and Internet Access For Third Quarter Earnings Conference Call Wednesday, October 25, Live at 4:30 p.m. Eastern Time SAN DIEGO, Oct. 12 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that it will host both a telephone and
View HTML
Toggle Summary Arena Pharmaceuticals Announces 2000 Second Quarter Results
Arena Pharmaceuticals Announces 2000 Second Quarter Results SAN DIEGO, Sept. 6 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today reported results for the quarter ended June 30, 2000. During the second quarter 2000, the Company reported revenues of $1.3 million versus no revenues for
View HTML